Avanos Medical Inc (AVNS)
Gross profit margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross profit (ttm) | US$ in thousands | 381,300 | 380,700 | 383,300 | 385,500 | 395,200 | 414,700 | 429,300 | 446,400 | 449,100 | 429,100 | 409,400 | 380,200 | 364,300 | 356,300 | 361,700 | 362,500 | 373,300 | 394,100 | 393,300 | 405,500 |
Revenue (ttm) | US$ in thousands | 687,800 | 681,500 | 682,400 | 680,100 | 705,700 | 749,900 | 780,700 | 814,300 | 820,000 | 795,900 | 777,900 | 761,300 | 744,600 | 736,200 | 737,800 | 715,100 | 714,800 | 719,600 | 705,300 | 713,800 |
Gross profit margin | 55.44% | 55.86% | 56.17% | 56.68% | 56.00% | 55.30% | 54.99% | 54.82% | 54.77% | 53.91% | 52.63% | 49.94% | 48.93% | 48.40% | 49.02% | 50.69% | 52.22% | 54.77% | 55.76% | 56.81% |
December 31, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $381,300K ÷ $687,800K
= 55.44%
Avanos Medical Inc has shown fluctuations in its gross profit margin over the past few years. The gross profit margin is a key financial metric that indicates the percentage of revenue that exceeds the cost of goods sold.
From March 31, 2020, to December 31, 2021, the company experienced a gradual decline in its gross profit margin from 56.81% to 48.93%. This could indicate pricing pressures, increased production costs, or inefficiencies in managing costs during this period.
However, from March 31, 2022, onwards, Avanos Medical Inc managed to reverse this trend with its gross profit margin improving to 56.00% by December 31, 2023. This improvement suggests that the company may have implemented cost-cutting measures, improved operational efficiencies, or achieved better pricing strategies.
Overall, the company's gross profit margin has demonstrated resilience and recovery, stabilizing within the range of 55% to 56% towards the end of 2024. This indicates that Avanos Medical Inc has been able to effectively manage its production costs and maintain healthy profitability levels in recent periods.
Peer comparison
Dec 31, 2024